Clover Health Stock Soars 8.33%, Hits Intraday High of $3.34

Clover Health Investments Corp., a small-cap player in the insurance industry, has seen a notable increase of 8.33% on September 23, 2025. The stock reached an intraday high of USD 3.34, reflecting a significant movement in its trading activity.
In terms of performance metrics, Clover Health has shown a year-to-date increase of 13.81%, outperforming the S&P 500, which has seen a more modest gain. Over the past year, the stock has generated a return of 10.47%, while profits have surged by 82.2%. However, the company faces challenges with a return on equity of -12.39% and an average operating profit growth rate of 0%, indicating potential concerns regarding long-term fundamental strength.

Clover Health's market capitalization stands at USD 1,456 million, and it currently does not offer a dividend yield. The stock's price-to-book ratio is 4.23, suggesting a premium valuation relative to its book value. As the company navigates its market position, these financial indicators provide insight into its current standing within the insurance sector.